A polymorphism in the growth hormone receptor is associated with height in children with Prader–Willi syndrome
Authors:
- 3 November 2011
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 155 (12) , 2970-2973
Abstract
The exon‐3 deletion polymorphism (d3, Database of Genomic Variants ID: Variation_64191) in the growth hormone receptor (GHR) gene is associated with increased growth response to growth hormone (GH) therapy in GH‐deficient patients. However, an association of the GHR genotype with height has not yet been reported in Prader–Willi syndrome (PWS). The aim of this study was to assess the association of GHR alleles with height before starting GH therapy in patients with PWS. Seventy‐four patients with PWS were genotyped and their medical records were retrospectively reviewed (45 males and 29 females, median age 8.7 years). One hundred normal controls, with known final height, were also genotyped. The GH‐exon 3 locus was genotyped using a PCR multiplex assay. The distribution of alleles in the patients with PWS was not different from controls [(fl/fl n = 53 (72%), fl/d3 n = 21 (28%)) in PWS vs. (fl/fl n = 72(72%), fl/d3 n = 26(26%), and d3/d3 n = 2(2%)]. However, patients with PWS carrying a d3 allele had significantly greater height standard deviation scores (SDS) (P = 0.025) and higher insulin‐like growth factor I (IGF‐I) level (P = 0.041), although the age at the start of GH therapy, weight, BMI, and body fat were not different. The d3 allele was associated with height and IGF‐I levels before GH therapy and suggests that even before GH therapy, d3 allele may influence height through GH secretion.Keywords
This publication has 13 references indexed in Scilit:
- The growth hormone receptor (GHR) exon 3 polymorphism and its correlation with metabolic profiles in obese Chinese childrenPediatric Diabetes, 2011
- Impact of the Exon 3-Deleted Growth Hormone (GH) Receptor Polymorphism on Baseline Height and the Growth Response to Recombinant Human GH Therapy in GH-Deficient (GHD) and Non-GHD Children with Short Stature: A Systematic Review and Meta-AnalysisThe Journal of Clinical Endocrinology & Metabolism, 2009
- Growth Hormone Receptor Exon 3 Isoforms and Their Implication in Growth Disorders and TreatmentHormone Research in Paediatrics, 2009
- Homozygosity of the d3‐growth hormone receptor polymorphism is associated with a high total effect of GH on growth and a low BMI in girls with Turner syndromeClinical Endocrinology, 2007
- Common genetic variation in eight genes of the GH/IGF1 axis does not contribute to adult height variationHuman Genetics, 2007
- Pituitary abnormalities in Prader–Willi syndrome and early onset morbid obesityAmerican Journal of Medical Genetics Part A, 2007
- The d3-Growth Hormone (GH) Receptor Polymorphism Is Associated with Increased Responsiveness to GH in Turner Syndrome and Short Small-for-Gestational-Age ChildrenThe Journal of Clinical Endocrinology & Metabolism, 2006
- A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormoneNature Genetics, 2004
- Endocrine Dysfunction in Prader-Willi Syndrome: A Review with Special Reference to GHEndocrine Reviews, 2001
- Species-specific Alternative Splice Mimicry at the Growth Hormone Receptor Locus Revealed by the Lineage of Retroelements during Primate EvolutionJournal of Biological Chemistry, 2000